Peristem

Peristem is a Canadian biotechnology company specializing in the development of advanced cell therapies derived from the perivascular region of the human umbilical cord. Spun out from the University of Toronto, the company's core technology centers on Human Umbilical Perivascular Cells (HUCPVCs), a unique population of mesenchymal stem cells (MSCs) harvested from Wharton's Jelly. These cells exhibit superior proliferative potential and potent immunomodulatory characteristics compared to traditional bone marrow-derived MSCs, making them ideal for regenerative medicine. Peristem targets a broad range of clinical applications, including bone graft substitutes, myocardial repair, and the treatment of inflammatory and autoimmune diseases. By providing a non-invasive, ethically sourced, and scalable cell source, Peristem aims to deliver off-the-shelf therapeutic solutions for complex medical conditions.